We are a leading pharmaceutical contaract research and development company. It specializes in development of advanced formulation technology and new drug delivery systems.Founded in 1996.The founders of the company are well trained in the US. In addition, during the past ten years, CancerAPI has invested heavily in advanced pharmaceutical technologies and established several key formulation technologies and platforms.
CancerAPI has a strong professional team consists of more than 10 seasoned scientists. With privileged access to local resources and close relationships with major industrial and academic pharmaceutical research institutes in both Chinese and US, such as Shanghai Medical and Pharmaceutical Engineer Institute, Shenyang Pharmaceutical University, China Pharmaceutical University, and so forth,
CancerAPI has established a professional system to manage the entire drug discovery process from early drug discovery, animal feasibility study, clinical trials, regulatory registration and commercial manufacture and distribution, and has attained a great reputation from both clients in China and overseas.